Presentation patterns and outcomes in patients with colorectal cancer seeking the emergency department for consultation

Background: Patients with colorectal cancer may seek the emergency department for symptoms related to chemotherapy and radiotherapy side effects as well as those from the disease itself and from surgery complications. Objectives: To establish the epidemiological and clinical profile of colorectal cancer patients that look for consultations in the emergency department. Methods: Retrospective study of emergency room charts from colorectal cancer patients that consulted in a single oncological hospital for the period of 1 year. Results: Four hundred and forty-six consultations were identified (49.5% males and 50.5% females) with a mean age of 63 years and with advanced disease (most with tumor, node, metastases [TNM] stages III and IV). The most common complaint was abdominal pain (27.5%), followed by nausea (4.7%; more commonly seen in females with p =0.03) and bladder symptoms (4.7%; more commonly seen in males, with p =0.003). Infections (10.3%) and acute abdominal pain (9.1%) were the most frequent diagnoses. About 18% of them were admitted to the hospital and 80% were discharged home. Conclusion: The profile of patients with colorectal cancer seeking the emergency department comprises patients with advanced disease and a similar proportion of males and females. Symptom-driven complaints were the most frequent reason for consultations. (AU)

Symptom assessment after nasal irrigation with xylitol in the postoperative period of endonasal endoscopic surgery / Avaliação dos sintomas após irrigação nasal com xilitol no período pós-operatório de cirurgias endoscópicas endonasais

Abstract Introduction: Chronic rhinosinusitis is an inflammatory condition of the nasal cavity and the paranasal sinuses that requires multifactorial treatment. Xylitol can be employed with nasal irrigation and can provide better control of the disease. Objective: To evaluate the association between the effects of nasal lavage with saline solution compared to nasal lavage with a xylitol solution. Methods: Fifty-two patients, divided into two groups (n = 26 in the "Xylitol" group and n = 26 in the "Saline solution" group) answered questionnaires validated in Portuguese (NOSE and SNOT-22) about their nasal symptoms and general symptoms, before and after endonasal endoscopic surgery and after a period of 30 days of nasal irrigation. Results: The "Xylitol" group showed significant improvement in pain relief and nasal symptom reduction after surgery and nasal irrigation with xylitol solution (p < 0.001). The "Saline solution" group also showed symptom improvement, but on a smaller scale. Conclusion: This study suggests that the xylitol solution can be useful in the postoperative period after endonasal endoscopic surgery, because it leads to a greater reduction in nasal symptoms.

Resumo Introdução: Rinossinusite crônica é um quadro de inflamação da cavidade nasal e dos seios paranasais que necessita de tratamento multifatorial. O xilitol pode ser associado às irrigações nasais e pode prover melhor controle da doença. Objetivo: Avaliar a relação entre os efeitos da lavagem nasal com solução fisiológica em comparação à lavagem nasal com solução de xilitol. Método: Divididos em dois grupos (n = 26 no grupo Xilitol e n = 26 no grupo Soro), 52 pacientes responderam à questionários validados em língua portuguesa (NOSE e SNOT-22) sobre seus sintomas nasais e sintomas gerais, antes e depois de cirurgia endoscópica endonasal e após um período de 30 dias de irrigação nasal. Resultados: O grupo Xilitol apresentou melhoria significativa dos sintomas de dor e sintomas nasais após a cirurgia e a irrigação nasal com solução de xilitol (p < 0,001). O grupo Soro também apresentou melhoria dos sintomas, porém em menor escala. Conclusão: Este estudo sugere que a solução de xilitol pode ser usada no período pós-operatório de cirurgia endoscópica endonasal por levar a uma maior redução nos sintomas nasais.

Estratégias de avaliação do sintoma de fadiga em pessoas com doença renal crônica: revisão sistemática / Strategies for assessing the symptom of fatigue in people with chronic kidney disease: systematic review / Estrategias para evaluar el síntoma de fatiga en personas con enfermedad renal crónica: revisión sistemática

Introdução: A avaliação do sintoma de fadiga em pessoas com doença renal crônica tem sido um desafio para enfermagem por tratar-se de um sintoma subjetivo e associado a outras comorbidades. Objetivo: Conhecer as estratégias de avaliação do sintoma de fadiga em pessoas com doença renal crônica. Método: Estudo de revisão sistemática da literatura, realizada em três bases de dados (PubMed/MEDLINE, BIREME e LILACS), utilizando os descritores "Renal Insufficiency, Chronic", "Fatigue" e foram verificados os níveis de evidência dos estudos. Para análise dos dados utilizou-se um instrumento de avaliação dos itens e análise descritiva. Resultados: Atenderam aos critérios de inclusão 36 estudos que avaliaram a prevalência de fadiga em 7.587 pessoas com doença renal crônica em 15 países, em quatro continentes; os fatores preditivos foram as características individuais, psicossociais, clínicas e comorbidades; as estratégias de avaliação incluíram 40 instrumentos, informações sociodemograficas e clínicas. Quanto ao nível de evidência, os estudos se concentram nos níveis três e quatro. Considerações finais: A prevalência e os fatores preditivos podem ser manejados com o uso de estratégias de avaliação, válidas para avaliar o sintoma de fadiga em pessoas com doença renal crônica, bem como, com intervenções confiáveis, como a suplementação nutricional, hipnose, acupuntura, ergometria de pernas intradialíticas e apoio social, os quais podem ser adotados pela enfermagem em unidades de nefrologia para promoverem a redução da prevalência do sintoma de fadiga.

Background: The evaluation of fatigue symptom in people with chronic kidney disease has been a challenge for nursing because it is a subjective symptom and associated with other comorbidities. Aim: To analyze the scientific evidence on the prevalence, predictive factors and strategies for the assessment of fatigue symptoms in people with chronic kidney disease. Method: Systematic literature review study conducted in three databases (PubMed / MEDLINE, BIREME and LILACS) using the descriptors "Renal Insufficiency, Chronic", "Fatigue" and the levels of evidence of the studies were verified. For data analysis we used an item evaluation instrument and descriptive analysis. Results: Inclusion criteria were 36 studies that assessed the prevalence of fatigue in 7,587 people with chronic kidney disease in 15 countries in four-continents; predictive factors were individual, psychosocial, clinical and comorbidities; the evaluation strategies included 40 instruments, sociodemographic and clinical information. As for the level of evidence, studies focus on levels three and four. Final considerations: Prevalence and predictive factors can be managed using valid assessment strategies to assess the symptom of fatigue in people with chronic kidney disease, as well as with reliable interventions such as nutritional supplementation, hypnosis, acupuncture, intradialitic leg ergometry and social support, which can be adopted by nursing in nephrology units to promote a reduction in the prevalence of fatigue symptoms.

Introducción: La evaluación de los síntomas de fatiga en personas con enfermedad renal crónica ha sido un desafío para la enfermería porque es un síntoma subjetivo y está asociado con otras comorbilidades. Objetivo: analizar la evidencia científica sobre la prevalencia, los factores predictivos y las estrategias para la evaluación de los síntomas de fatiga en personas con enfermedad renal crónica. Método: Estudio sistemático de revisión de literatura realizado en tres bases de datos (PubMed / MEDLINE, BIREME y LILACS) utilizando los descriptores "Insuficiencia renal, crónica", "Fatiga" y los niveles de evidencia de los estudios fueron verificados. Para el análisis de datos utilizamos un instrumento de evaluación de ítems y un análisis descriptivo. Resultados: Los criterios de inclusión fueron 36 estudios que evaluaron la prevalencia de fatiga en 7,587 personas con enfermedad renal crónica en 15 países en cuatro continentes; los factores predictivos fueron individuales, psicosociales, clínicos y comorbilidades; Las estrategias de evaluación incluyeron 40 instrumentos, información sociodemográfica y clínica. En cuanto al nivel de evidencia, los estudios se centran en los niveles tres y cuatro. Consideraciones finales: la prevalencia y los factores predictivos se pueden manejar utilizando estrategias de evaluación válidas para evaluar los síntomas de fatiga en personas con enfermedad renal crónica, así como con intervenciones confiables como suplementos nutricionales, hipnosis, acupuntura, ergometría intradialítica de piernas y apoyo social, que puede ser adoptado por enfermería en unidades de nefrología para promover una reducción en la prevalencia de síntomas de fatiga.

In the wake of the pandemic: preparing for long COVID

This brief’s key messages are:COVID-19 can cause persistent ill-health. Around a quarter of people who have had the virus experience symptoms that continue for at least a month but one in 10 are still unwell after 12 weeks. This has been described by patient groups as “Long COVID”. Our understanding of how to diagnose and manage Long COVID is still evolving but the condition can be very debilitating. It is associated with a range of overlapping symptoms including generalized chest and muscle pain, fatigue, shortness of breath, and cognitive dysfunction, and the mechanisms involved affect multiple system and include persisting inflammation, thrombosis, and autoimmunity. It can affect anyone, but women and health care workers seem to be at greater risk. Long COVID has a serious impact on people’s ability to go back to work or have a social life. It affects their mental health and may have significant economic consequences for them, their families and for society. Policy responses need to take account of the complexity of Long COVID and how what is known about it is evolving rapidly. Areas to address include: The need for multidisciplinary, multispecialty approaches to assessment and management;Development, in association with patients and their families, of new care pathways and contextually appropriate guidelines for health professionals, especially in primary care to enable case management to be tailored to the manifestations of disease and involvement of different organ systems; The creation of appropriate services, including rehabilitation and online support tools; Action to tackle the wider consequences of Long COVID, including attention to employment rights, sick pay policies, and access to benefit and disability benefit packages; Involving patients both to foster self-care and self-help and in shaping awareness of Long COVID and the service (and research) needs it generates; and implementing well-functioning patient registers and other surveillance systems; creating cohorts of patients; and following up those affected as a means to support the research which is so critical to understanding and treating Long COVID.

Cluster de Sintomas e o Impacto na Qualidade de Saúde Global de Pacientes com Câncer Avançado / Symptom Cluster and the Impact on the Global Health Quality of Patients with Advanced Cancer / Grupo de Síntomas y el Impacto en la Calidad Global de la Salud de los Pacientes con Cáncer Avanzado

Introdução: Os pacientes com câncer podem apresentar múltiplos sintomas que se inter-relacionam, formando os chamados clusters ou agrupamentos de sintomas. Objetivo: Avaliar a relação entre um cluster de sintomas e a qualidade de saúde global de pacientes com câncer avançado. Método: Estudo analítico, transversal, com 146 pacientes. Foram utilizados instrumentos de caracterização sociodemográfica e de avaliação de qualidade de vida. Para análise dos dados, aplicaram-se os testes Kolmogorov-Smirnov, Mann-Whitney e Kruskal-Wallis. A coleta de dados foi realizada entre julho de 2019 e fevereiro de 2020 e utilizado o questionário 30-item European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30), versão 3. Resultados: A correlação de Spearmanmostrou-se positiva entre o escore final da escala de sintomas e o escore final da avaliação global da saúde (ρ=0,605; p<0,001). Além disso, observou-se que o incremento de 1 ponto na pergunta: "Precisou descansar?" associou-se com aumento de 5,87 pontos no escore da qualidade da saúde global (p<0,01); para a pergunta "Sentiu-se cansado/a?", 6,14 pontos (p<0,01); e "Teve falta de ar?", 5,08 pontos (p<0,01). Conclusão: Existe uma correlação positiva entre o cluster de sintomas composto por dor, fadiga, dispneia, náusea, vômito, insônia, inapetência, constipação, diarreia e a qualidade de saúde global de pacientes com câncer.

Introduction: Patients with cancer can present multiple symptoms that are interrelated, forming the so-called clusters or groups of symptoms. Objective: To evaluate the relationship between a cluster of symptoms and the global quality of life of patients with advanced cancer. Method:Analytical, cross-sectional study with 146 patients. Sociodemographic characterization and quality of life assessment instruments were used. For data analysis, the Kolmogorov-Smirnov, Mann-Whitney, and Kruskal-Wallis tests were applied. Data collection was carried out between July 2019 and February 2020 and the European Organization for Research and Treatment of Cancer Core Quality of Life Questionnaire (EORTC QLQ-C30), version 3, was adopted. Results: Spearman's correlation was positive between the final score of the symptom scale and the final score of the global health assessment (ρ=0.605; p<0.001). In addition, it was observed that the increase of 1 point in the question "Did you need to rest?" was associated with an increase of 5.87 points in the global health quality score (p<0.01), for the question "Did you feel tired?", 6.14 points (p<0.01) and "Did you have shortness of breath?", 5.08 points (p<0.01). Conclusion: There is a positive correlation between the cluster of symptoms formed by pain, fatigue, dyspnea, nausea, vomiting, insomnia, lack of appetite, constipation, diarrhea and the overall health quality of patients with cancer.

Introducción: Los pacientes con cáncer pueden presentar múltiples síntomas que están interrelacionados, formando los llamados grupos o grupos de síntomas. Objetivo: Evaluar la relación entre uno grupo de síntomas y la calidad de vida general de los pacientes con cáncer avanzado. Método: Estudio analítico, transversal, con 146 pacientes. Se utilizaron instrumentos de caracterización sociodemográfica y de evaluación de la calidad de vida. Para el análisis de datos, se aplicaron las pruebas de Kolmogorov-Smirnov, Mann-Whitney y Kruskal-Wallis. La recolección de datos se llevó a cabo entre julio de 2019 y febrero de 2020 y se utilizó el cuestionario de calidad de vida básica de la Organización Europea para la Investigación y el Tratamiento del Cáncer (EORTC QLQ-C30), versión 3. Resultados: La correlación de Spearman fue positiva entre el puntaje final de la escala de síntomas y el puntaje final de la evaluación de salud global (ρ=0,605; p<0,001). Además, se observó que el aumento de 1 punto en la pregunta "¿Necesitabas descansar?" se asoció con un aumento de 5,87 puntos en el puntaje de calidad de salud global (p<0,01); para la pregunta "¿Se sintió cansado?", 6,14 puntos (p<0,01); y "¿Tuvo dificultad para respirar?", 5,08 puntos (p<0,01). Conclusión: Existe una correlación positiva entre el conjunto de síntomas compuestos por dolor, fatiga, disnea, náuseas, vómitos, insomnio, falta de apetito, estreñimiento, diarrea y la calidad de salud general de los pacientes con cáncer.

Implicaciones del COVID-19 (SARS-CoV-2) para la práctica anestesiológica / Implications of COVID-19 (SARS-CoV-2) for the anesthesiological practice

El objetivo de este artículo es revisar las características del SARS-CoV-2, los aspectos clínico-epidemiológicos de COVID-19 y las implicaciones que tienen para los anestesiólogos al realizar procedimientos generadores de aerosoles. Se realizó una búsqueda en las bases de datos PubMed, Scopus, SciELO y Web of Science hasta el 9 de abril de 2020, utilizando las palabras: "COVID-19 or COVID19 or SARS-CoV-2 and anesthesiology or anesthesia". Se incluyeron 48 artículos con información sobre el manejo del paciente en el perioperatorio o en la unidad de cuidados intensivos ante la sospecha o confirmación de infección por SARS-CoV-2. En general, se recomienda el aplazamiento de las cirugías electivas por no más de seis a ocho semanas, de acuerdo a las condiciones clínicas de los pacientes. En el caso de cirugías de urgencia o emergencia, se revisan tópicos del sistema de protección personal así como las estrategias recomendadas para la realización de los procedimientos.

The purpose of this article is to review the characteristics of SARS-CoV-2, the clinical-epidemiological aspects of COVID-19, and the implications anesthesiologists when performing aerosol-generating procedures. A search of PubMed/MEDLINE, Scopus, SciELO, and Web of Science databases was performed until April 9, 2020, using the words: "COVID-19 or COVID19 or SARS-CoV-2 and anesthesiology or anesthesia". Forty-eight articles with information on the management of the patient in the perioperative period or the intensive care unit when suspected or confirmed SARS-CoV-2 infection were included. In general, the postponement of elective surgeries for no more than 6 to 8 weeks, depending on the clinical condition of the patients is recommended. In the case of urgent or emergency surgeries, we review the use of personal protection gear, as well as the recommended strategies for carrying out the procedure.

Padrão Sintomatológico em Pacientes do Câncer Colorretal de acordo com a Idade / Symptom Pattern in Colorectal Cancer Patients according to Age / Patrón de Síntomas en Pacientes con Cáncer Colorrectal según la Edad

Introdução: O câncer colorretal está entre os tipos de câncer mais comuns na população brasileira e mundial com altos índices de mortalidade. Alguns estudos mostram que há uma diferença de carga sintomatológica para esse tipo de câncer entre adultos jovens e idosos que, consequentemente, podem deteriorar a qualidade de vida nesses pacientes. Objetivo: Investigar a diferença no padrão de sintomas entre pacientes adultos e idosos com câncer de cólon e reto. Método: Estudo transversal que utilizou um conjunto de dados sobre a prevalência de sintomas entre pacientes com câncer colorretal atendidos no Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA), por meio de um inventário de sintomas recentemente adaptado para o Brasil. Resultados: Foram entrevistados 348 pacientes, destes, 101 pacientes eram adultos jovens (29,1%) e 247 idosos (70,9%). Obteve-se diferença entre os sintomas analisados para dor (p=0,033), nervosismo (p=0,013), sonolência (p=0,033), tristeza (p=0,003), problemas com desejo sexual ou atividade sexual (p=0,014), falta de apetite (p=0,028), irritação (p=0,013), mudança nos gostos dos alimentos (p=0,042), perda de cabelo (p=0,002) e "eu não pareço mais o mesmo" (p<0,001). Conclusão: A carga sintomatológica frente ao câncer colorretal pode apresentar distinção conforme a idade. Isso é relevante, pois reforça a ideia de individualizar o tratamento para melhorar a assistência e, consequentemente, a qualidade de vida desses doentes.

Introduction: Colorectal cancer is among the most common types of cancer in the Brazilian and world population, with high rates of mortality. Some studies show that there is a difference in the symptomatic burden for this cancer among young adults and elderly individuals, which can deteriorate the quality of life of these patients. Objective: To investigate the difference in the pattern of symptoms among young adults and elderly patients with colon and rectum cancer. Method: Cross-sectional study using dataset on the prevalence of symptoms among colorectal cancer patients attended at the National Cancer Institute José Alencar Gomes da Silva (INCA) through a recently adapted inventory of symptoms for Brazil. Results: A total of 348 patients were interviewed, of which 101 were young adults (29,1%) and 247 (70.9%) were elderly individuals. There was a difference between the symptoms analyzed for pain (p=0.033), nervousness (p=0.013), drowsiness (p=0.033), sadness (p=0.003), problem with sexual interest or activity (p=0.014), loss of appetite (p= 0.028), irritation (p=0.013), change of food taste (p=0.042), hair loss (p=0.002.) and "I don't look like myself " (p<0.001). Conclusion: The symptomatic burden of colorectal cancer may differ according to age. This is relevant because reinforces the idea of individualizing the treatment to improve the care and, consequently, the quality of life of these patients.

Introducción: El cáncer colorrectal se encuentra entre los tipos de cáncer más comunes em la población brasileña y mundial, con altas tasas de mortalidad. Algunos estudios muestran que existe una diferencia en la carga sintomática para este tipo de cáncer entre adultos jóvenes y viejos, lo que en consecuencia puede deteriorar la calidad de vida en estos pacientes. Objetivo: Investigar la diferencia en el patrón de síntomas entre pacientes adultos y ancianos con cáncer de colon y recto. Método: Estudio transversal que utiliza un conjunto de datos de prevalencia de síntomas entre pacientes con cáncer colorrectal tratados en el Instituto Nacional del Cáncer José Alencar Gomes da Silva (INCA) a través de un inventario de síntomas recientemente adaptado para o Brasil. Resultados: Se entrevisto a 348 pacientes, de estos 101 pacientes eran adultos jóvenes (29,1%) y 247 en acianos (70,9%). Hubo una diferencia entre los síntomas analizados para el dolor (p=0,003), nerviosismo (p=0,013), somnolencia (p=0,033), tristeza (p=0,003), problemas con el deseo sexual o actividad sexual (p=0,014), falta de apetito (p=0,028), irritación (p=0,013), cambio en los gustos de los alimentos (p=0,042), pérdida de cabello (p=0,002) y "Ya no me veo igual"(p<0,001). Conclusión: La carga sintomática del cáncer colorrectal se puede distinguir según la edad. Esto es relevante porque refuerza la idea de individualizar el tratamiento para mejorar la atención y, en consecuencia, la calidad de vida de estos pacientes.

Covid-19 (sars-cov-2 infection) information for patients with predialytic chronic kidney disease / Informações para pacientes com doença renal crônica pré-dialítica sobre Covid-19 (infecção pelo SARS-CoV-2)

ABSTRACT Patients with Chronic Kidney Disease are among those individuals at increased risk for developing more serious forms of Covid-19. This increased risk starts in the pre-dialysis phase of the disease. Providing useful information for these patients, in language that facilitates the understanding of the disease, can help nephrologists and other healthcare professionals to establish a more effective communication with these patients and help minimize contagion and the risks of serious illness in this population.

RESUMO Pacientes com Doença Renal Crônica estão entre os indivíduos de risco aumentado para desenvolvimento de formas mais sérias de Covid-19. Esse risco aumentado inicia-se já na fase pré-dialítica da doença. Fornecer informações úteis para esses pacientes, em linguagem que facilite o entendimento da doença, pode ajudar nefrologistas e outros profissionais de saúde a estabelecerem uma comunicação mais efetiva com esses pacientes e ajudar a minimizar o contágio e os riscos de doença grave nessa população.

Recommendations of the brazilian society of nephrology regarding pediatric patients on renal replacement therapy during the covid-19 pandemic / Recomendações da sociedade brasileira de nefrologia para pacientes pediátricos em terapia de substituição renal durante a pandemia de covid-19

ABSTRACT Introduction The impact of the new coronavirus (SARS-COV-2) and its worldwide clinical manifestations (COVID-19) imposed specific regional recommendations for populations in need of specialized care, such as children and adolescents with kidney diseases, particularly in renal replacement therapies (RRT). We present the recommendations of the Brazilian Society of Nephrology regarding the treatment of pediatric patients with kidney diseases during the COVID-19 pandemic. Methods Articles and documents from medical societies and government agencies on specific recommendations for children on RRT in relation to COVID-19 as well as those focused on epidemiological aspects of this condition in Brazil Were evaluated and analyzed. Results We present recommendations on outpatient care, transportation to dialysis centers, peritoneal dialysis, hemodialysis, and kidney transplantation in children and adolescents during the COVID-19 pandemic in Brazil. Discussion Despite initial observations of higher mortality rates in specific age groups (the elderly) and with comorbidities (obese, diabetics, and those with cardiovascular diseases), patients with chronic kidney disease (CKD) on RRT are particularly prone to develop COVID-19. Specific measures must be taken to reduce the risk of contracting SARS-CoV-2 and developing COVID-19, especially during transport to dialysis facilities, as well as on arrival and in contact with other patients.

RESUMO Introdução O impacto do novo coronavírus (SARS-CoV-2) e as suas manifestações clínicas (Covid-19) em todo o mundo impôs recomendações regionais específicas a populações que necessitam de cuidados especializados, como crianças e adolescentes com doenças renais, particularmente em terapias de substituição renal (TRS). Apresentamos as recomendações da Sociedade Brasileira de Nefrologia em relação ao tratamento de pacientes pediátricos com doenças renais durante a pandemia Covid-19. Método Foram avaliados e analisados os artigos e documentos sobre recomendações específicas para Covid-19 de sociedades médicas e órgãos governamentais sobre crianças em TRS, bem como aqueles focados em aspectos epidemiológicos dessa condição no Brasil. Resultados Apresentamos as recomendações sobre atendimento ambulatorial, transporte para centros de diálise, diálise peritoneal, hemodiálise e transplante renal em crianças e adolescentes durante a pandemia de Covid-19 no Brasil. Discussão Apesar das observações iniciais de taxas de mortalidade mais altas em grupos etários específicos (idosos) e com comorbidades (obesos, diabéticos e aqueles com doenças cardiovasculares), pacientes com doença renal crônica (DRC) em TRS apresentam risco significativo de evoluir com Covid-19. Medidas específicas devem ser tomadas para reduzir o risco de contrair SARS-CoV-2 e desenvolver a Covid-19, principalmente durante o transporte para instalações de diálise, bem como na chegada e no contato com outros pacientes.

COMDORA-SBN recommendations for patients with rare kidney diseases in relation to the Covid-19 pandemic / Recomendações do COMDORA-SBN a pacientes portadores de doenças renais raras em relação à pandemia de Covid-19

ABSTRACT During the Covid-19 pandemic, the issue is how to maintain adequate care for people with other diseases. In this document, the SBN Rare Diseases Committee (COMDORA) gives some guidelines on the care of patients with rare kidney diseases. These patients should follow the recommendations for the general population, bearing in mind that, as they have chronic kidney disease, they are included in the risk group for more serious outcomes if they develop Covid-19. Non-essential decision-making procedures should be postponed. In stable cases under appropriate treatment, we must choose to contact our patients remotely, using teleconsultations and home exam collections (if possible). In the presence of a symptom or sign of decompensation of the underlying disease, or infection with Sars-cov-2, advise the patient to seek medical assistance. The patient should not be waiting to get worse. Changes to the prescription should only be made on a scientific basis. Dosage suspension or change is not recommended, even in cases in which the patient needs to go to a center to receive his medication; in this case, the infusion center must follow the recommendations of the Ministry of Health. If the patient develops Covid-19 and uses any drugs, check the need for dose adjustment of the routine medications. Avoid the use of antimetabolics and anti-CD20 in patients with Covid-19, as they reduce viral clearance and predispose to bacterial infections. Contact between the patient and the medical team is essential; changes are recommended only with specialized medical guidance.

RESUMO Durante a pandemia da Covid-19, fica a questão de como manter o atendimento adequado aos portadores de outras doenças. O Comitê de Doenças Raras (COMDORA) da SBN neste documento dá algumas orientações ao atendimento de pacientes com doenças renais raras. Estes pacientes devem seguir as recomendações destinadas à população geral tendo em mente que, por serem portadores de doença renal crônica, estão incluídos no grupo de risco para desfechos mais graves, caso venham a desenvolver a Covid-19. Procedimentos não essenciais para tomada de decisão devem ser adiados. Deve-se optar por contatos a distância, como teleconsultas, e coletas de exames domiciliares (se possível) nos casos estáveis sob tratamento adequado. Na presença de sintoma ou sinal de descompensação da doença de base ou infecção pelo Sars-cov-2, orientar o paciente a procurar a equipe médica. O paciente não deve ficar esperando o quadro agravar-se. Alterações na prescrição só devem ser feitas com embasamento científico. Não se recomenda a suspensão ou alteração posológica, mesmo nos casos em que o paciente necessita ir a um centro para receber sua medicação; neste caso o centro de infusão deve seguir as recomendações do Ministério da Saúde. Caso o paciente desenvolva a Covid-19 e faça uso de alguma droga, verificar a necessidade de ajuste nas doses dos medicamentos rotineiros. Evitar o uso de antimetabólicos e antiCD20 nos pacientes com a Covid-9, por reduzirem o clareamento viral e predisporem a infecções bacterianas. O contato entre paciente e equipe médica é essencial; alterações são recomendadas apenas com orientação médica especializada.

Updated analysis of irritable bowel syndrome: a review of the literature / Análisis actualizado del síndrome de intestino irritable: una revisión de la literatura

Irritable bowel syndrome (IBS) is a chronic pathology with disorders of the bowel-brain interaction, characterized by abdominal pain localized anywhere in the abdomen as well as bowel habit alteration (constipation, diarrhea or mixed), in the absence of any disease that can cause these symptoms. With the updated concepts according to the latest meeting of experts in Rome 2016, our goal is to raise awareness about irritable bowel syndrome, by reviewing the literature regarding definition, classification, pathophysiology, clinical aspects, treatment, prognosis and the future. IBS is a chronic pathology, characterized by abdominal pain, at least 1 day per week in the last 3 months, associated with the alteration of the intestinal bowel habits. With a classification based on the alteration of intestinal bowel movements and in addition to constipation induced by opioids or narcotics, the etiology and pathophysiology are not well explained or well-known so far. The clinical aspects are based on the Rome IV criteria. A good doctor-patient relationship is key to reassuring the patient's doubts about his illness, which increases the chances of adherence to individualized treatment from patient to patient depending on the sing and symptoms that may manifest in those that include: dietary advice, psychological support, in some cases pharmacological prescription, suspension of medications or change medications, minimize the dose of drugs or suspend, according to the needs of the patient as is the case of opioids. The prognosis is still uncertain, and a promising future to illustrate new definitions, classifications, pathophysiologies, clinical aspects and treatments according to the type of clinical manifestation of each patient.

El síndrome del intestino irritable (SII) es una patología crónica con desordenes de la interacción cerebro intestino, caracterizado por dolor abdominal localizado en cualquier parte del abdomen además de alteración del hábito intestinal como (constipación, diarrea o mixto), en ausencia de alguna enfermedad que pueda causar estos síntomas. Con los conceptos actualizados conforme en la última reunión de expertos en Roma 2016, nuestra meta es dar a conocer más sobre el síndrome del intestino irritable, mediante revisión de la literatura en cuanto a definición, clasificación, fisiopatología, aspectos clínicos, tratamiento, pronóstico y el futuro. El SII es una patología crónica, caracterizado por dolor abdominal, por lo menos 1 día por semana en los últimos 3 meses, asociado a la alteración del hábito intestinal. Con una clasificación basada en la alteración de los hábitos intestinales y además de constipación inducida por opioides o narcóticos, la etiología y fisiopatología no están bien explicadas ni se conocen bien hasta el momento. Los aspectos clínicos son basados en los criterios de Roma IV. Una buena relación médico-paciente es clave para tranquilizar las dudas del paciente sobre su enfermedad, lo que aumenta las posibilidades de adherencia al tratamiento individualizado de paciente a paciente dependiendo de las sintomatologías y signos que puedan manifestar en los que incluyen: asesoramiento dietético, apoyo psicológico, en algunos casos cambiar medicación, disminuir al mínimo la dosis del medicamento o suspender, según las necesidades del paciente como son los casos de los opiodes. El pronóstico todavía incierto, y un futuro prometedor para ilustrar nuevas definiciones, clasificaciones, fisiopatologías, aspectos clínicos, tratamientos posiblemente de acuerdo con el tipo de manifestación clínica de cada paciente.

Síntomas subagudos y crónicos de la fiebre de chikungunya en un grupo de personas adultas en Ibagué, Colombia / Subacute and chronic symptoms of chikungunya fever in a group of adults in Colombia

Resumen Introducción. La fiebre de chikungunya en Colombia ocasiona una alerta en salud pública que se extiende en el tiempo, dadas las características subagudas y crónicas de la enfermedad. Objetivo. Describir los síntomas subagudos y crónicos en personas mayores de 18 años con fiebre de chikungunya en Ibagué, Colombia. Materiales y métodos. Se hizo un estudio descriptivo con muestreo en bola de nieve de 368 adultos de todas las comunas de Ibagué que presentaban síntomas de la fiebre de chikungunya de más de 12 días de duración. Resultados. Las articulaciones que presentaban dolor en la fase subaguda y crónica de la enfermedad fueron las de manos (84,2 %), rodillas (72,8 %) y tobillos (69,3 %); además de las articulaciones, la planta de los pies fue el sitio en que más frecuentemente se presentó dolor (48,8 %). El dolor articular en manos (p=0,017) y tobillos (p=0,001) y el dolor en la planta de los pies (p=0,002) fueron significativos en las mujeres. La fatiga o el cansancio generalizado se presentaron en el 58,9 % de las personas y se prolongó por más de un año en el 2,4 % de ellas. Conclusiones. Los síntomas de la fase subaguda y crónica de la fiebre de chikungunya coincidieron con los descritos en la literatura médica, su duración se extendió hasta por un año o más en algunos de los casos y su intensidad disminuyó con el tiempo. Los síntomas referidos fueron más comunes en las mujeres que en los hombres.

Abstract Introduction: In Colombia, chikungunya fever creates a warning in public health that extends over time given the subacute and chronic characteristics of the disease. Objective: To describe subacute and chronic symptoms in adult people who suffered chikungunya fever in the city of Ibagué, Colombia. Materials and methods: We conducted a descriptive study with snowball sampling in 368 adults from all the communes of Ibagué, Colombia, who had symptoms of chikungunya fever spanning for more than 12 days. Results: The joints that showed the greatest pain in the subacute and chronic phase of the disease were the hands with 84.2%, knees with 72.8%, and ankles with 69.3%. The soles of the feet were the non-articular areas with greater frequency of pain (48.8%). Joint pain in the hands (p=0.017) and ankles (p=0.001) and pain in the soles of the feet (p=0.002) were significant in women. General fatigue occurred in 58.9% of the subjects and in 2.4% of the population, it lasted for more than a year. Conclusions: The symptoms of the subacute and chronic phase of chikungunya fever were the same reported in the literature, they lasted up to a year or more, and decreased in intensity over time. The referred symptoms were more common in women than in men.

Cross-cultural adaptation and validation of the neurogenic bladder symptom score questionnaire for brazilian portuguese

ABSTRACT Objective: To cross-culturally adapt and check for the reliability and validity of the neurogenic bladder symptom score questionnaire to Brazilian Portuguese, in patients with spinal cord injury and multiple sclerosis. Materials and Methods: The questionnaire was culturally adapted according to international guidelines. The Brazilian version was applied in patients diagnosed with neurogenic bladder due to spinal cord injury or multiple sclerosis, twice in a range of 7 to 14 days. Psychometric properties were tested such as content validity, construct validity, internal consistency, and test-retest reliability. Results: Sixty-eight patients participated in the study. Good internal consistency of the Portuguese version was observed, with Cronbach α of 0.81. The test-retest reliability was also high, with an Intraclass Correlation Coefficient of 0.86 [0.76 - 0.92] (p<0.0001). In the construct validity, the Pearson Correlation revealed a moderate correlation between the Portuguese version of the NBSS and the Qualiveen-SF questionnaire (r = 0.66 [0.40-0.82]; p <0.0001). Conclusions: The process of cross-cultural adaptation and validation of the NBSS questionnaire for the Brazilian Portuguese in patients with neurogenic lower urinary tract dysfunction was concluded.

El control de la hipertensión arterial, aún sin definir / Arterial hypertension control: still without definition

RESUMEN El debate alrededor de las cifras de tensión arterial, y sobre todo las cifras a obtener mediante el tratamiento es en la actualidad un grave problema de salud. Se realizó una revisión sistemática en inglés y español de los principales artículos publicados en PubMed, Scielo y MEDLINE durante el periodo comprendido desde el año 2012 hasta 2018, acerca de la definición, evaluación y manejó de la tensión arterial. Todas las guías están de acuerdo en la toma de múltiples medidas de la tensión arterial para el diagnóstico, pero no para definir el control de la tensión, definir el control de la tensión arterial debe incluir una dimensión en el tiempo en un año por lo menos, y una proporción mínima de medidas donde debe pensar en la mitad de todas las medidas por lo menos, con medidas de tensión arterial tomadas por lo menos cada tres meses, por lo que sugerimos que un perfil anual de las cifras de tensión arterial debe ser considerado como un requisito mínimo para evaluar el control de la hipertensión arterial, este trabajo ha perfilado dos de los factores menos reconocidos: la necesidad de la intensificación del tratamiento después de la primera toma de tensión arterial por encima de las cifras deseadas, y el incremento de una nueva droga en vez de incrementar las dosis de las ya indicadas.

ABSTRACT The debate on the maintained arterial tension measure, and on the measure to obtain through the long term treatment, is currently a problem for the medical practitioner, due to the variation of arterial tension during the day at different hours because of the patients circadian cycle, and due to variations in different days according to the proper patient's situations or the environment around it, and the different seasons of the year. They make it difficult to know when arterial tension is within the parameters accepted as "controlled". The authors carried out a systematic review of documents published in PubMed, Scielo and MEDLINE in the period 2012-2018, both in English and Spanish, on the arterial tension definition, evaluation and management. The guidelines agree in taking arterial tension measures in different moments for the diagnosis, but not in defining tension control. Defining tension control should include a time dimension of at least a year, and a minimal proportion of measures within the parameters recognized as non-pathological or optimal on the basis of measures taken at least every three months. Therefore, the authors suggest that an annual profile of the arterial tension parameters should be considered as a minimal requirement to evaluate arterial hypertension control.

Caracterización epidemiológica de la infección por Leptospira spp. en caballos de trabajo y en personas ocupacionalmente expuestas en seis unidades de la Policía Nacional de Colombia / Epidemiological characterization of Leptospira spp. infection in working horses and in an occupationally exposed population in six Colombian police stations

Resumen Introducción. Los caballos de trabajo de la Policía Nacional tienen un estrecho contacto con sus manejadores y la población en general durante las actividades recreativas y de patrullaje, lo cual puede favorecer la transmisión de la leptospirosis en los caballos y el personal ocupacionalmente expuesto. Objetivo. Caracterizar epidemiológicamente la leptospirosis mediante pruebas de serología, urocultivo y reacción en cadena de la polimerasa (Polymerase Chain Reaction, PCR) en caballos de trabajo y personal con riesgo ocupacional pertenecientes a seis unidades de la Policía Nacional de Colombia. Materiales y métodos. Se evaluaron 153 caballos machos castrados y 123 personas en las seis unidades en los municipios de Manizales, Pereira, Armenia, Ibagué, Tuluá y Cali. Se utilizaron tres formatos estructurados para recabar información y se obtuvieron muestras sanguíneas de las personas y de los caballos, las cuales se procesaron con la prueba de aglutinación microscópica (Macroscopic Agglutination Test, MAT) para 24 serogrupos. Se practicó el examen clínico de los caballos y se obtuvieron muestras de orina para el urocultivo y la PCR convencional. Resultados. La seroprevalencia de Leptospira spp. fue de 3,25 % (n=4) en las personas y de 85 % (n=130) en los caballos. Entre los caballos, los serogrupos Djasiman y Shermani fueron los más prevalentes. El urocultivo fue positivo en el 64,7 % (99/153) de las muestras, en tanto que los análisis de PCR fueron negativos. Se encontró una asociación estadísticamente significativa de la frecuencia de salida de las instalaciones (p=0,009) y la presencia de fauna silvestre (p=0,051) con la infección por el serogrupo Shermani. Conclusión. Las características epidemiológicas de la leptospirosis en los caballos sugieren una presentación endémica de la infección y su papel como reservorios de la bacteria; sin embargo, debe dilucidarse la patogenia de la enfermedad con estudios complementarios.

Abstract Introduction: Police working horses are in close contact with their managers and the general population during recreational and patrol activities, which can favor the transmission of leptospirosis among the horses and the occupationally exposed personnel. Objective. To characterize epidemiologically leptospirosis through serology, urine culture and PCR in working horses and in the occupationally exposed population in six police stations in Colombia. Materials and methods. We tested 153 castrated male horses and 123 people in six police stations in the municipalities of Manizales, Pereira, Armenia, Ibagué, Tuluá, and Cali. Three structured formats were applied and blood samples were obtained from people and horses, which were processed with the Macroscopic Agglutination Test, (MAT) for 24 serogroups. Horses were subject to a clinical examination, and urine samples were obtained for urine culture and conventional PCR. Results. The seroprevalence of human Leptospira spp. was 3.25% (n=4) while in horses it was 85% (n=130). Among the horses, serogroups Djasiman and Shermani were the most prevalent. The urine culture was positive in 64.7% (99/153) of the samples, whereas PCR analyzes were negative. A statistically significant association was found between the frequency of exiting the facilities (p=0.009) and the presence of wildlife (p=0.0051) with the infection by serogroup Shermani. Conclusion. The epidemiological characteristics of leptospirosis in horses suggest an endemic presentation of the infection and its role as reservoirs of the bacteria; however, it is necessary to elucidate the pathogenesis of the disease with complementary studies.

Eosinofilia duodenal en pacientes Colombianos con dispepsia funcional: un estudio de casos y controles / Duodenal eosinophilia in functional dyspepsia in a Colombian sample: a case-control study

Introducción: La dispepsia funcional (DPF) es una entidad compleja cuya fisiopatología no está claramente definida. Existen alteraciones motoras gastroduodenales y recientemente se ha dado importancia a la eosinofilia duodenal. Objetivo: El objetivo de este estudio fuedeterminar si existe asociación entre eosinofilia duodenal y DPF. Materiales y métodos: Estudio de casos y controles. Pacientes mayores de 18 años con dispepsia según ROMA IV, a quienes se descartó DP orgánica con endoscopia alta (EVDA). Los controles fueron pacientes con anemia ferropénica y diarrea crónica a quienes de rutina se toman biopsias tanto del estómago como del duodeno. Se calcularon 70 pacientes en cada grupo. La información se recolectó en un formulario específico. Resultados: Hubo 243 pacientes elegibles. Se incluyeron 84 pacientes en grupo. El 80% eran mujeres. Edad promedio 53,6 años. Se encontró eosinofilia duodenal con diferencia significativa en los pacientes con saciedad precoz (p=0,01). No hubo diferencia significativa en los pacientes con llenura posprandial (p=0,63), dolor o ardor epigástrico (p=0,26), síntomas de reflujo gastroesofágico (p=0,13), alergia e intolerancia a alimentos (p=0,42) y tabaquismo (p=0,28). Asimismo, no se encontró relación entre mastocitosis duodenal y saciedad precoz (p=0,98), llenura posprandial (p=0,78) y dolor o ardor epigástrico (p=0,82). Conclusiones: La eosinofilia duodenal fue más frecuente en pacientes con DPF que tenían saciedad precoz.

Introduction: Functional dyspepsia (FD) is a complex symptom. Currently there are multiple therapeutic options that are used for the management of these patients; however, FD therapies are based on symptomatic control and do not address the pathophysiological pathways involved in its development. The duodenum has been proposed as a key site to understand the complex pathophysiology involved in FD. Objective: The aim of the study is to determine duodenal eosinophilia in patients with FD and establish the clinical-pathological correlation with the cardinal symptoms of dyspepsia. Material and methods: Case-control study. Patients older than 18 years with dyspepsia according to the Rome IV criteria, and upper gastrointestinal endoscopy normal (FD group).Patients with iron deficiency anemia and chronic diarrhea (control group). Biopsies were taken in the stomach, duodenal bulb and second portion of duodenum. A sample size of 140 patients (70 patients in the FD group and 70 patients in the control group) was calculated. The collected information was described and analyzed by conventional statistical techniques. Results: 243 patients were recruited. 84 patients were included in the FD group and 84 patients in the control group. 135 patients were women (80.3%). The mean age was 53.6 years (SD 14.9). Duodenal eosinophilia was found with significant difference in patients with early satiety (p=0.01). There was no difference in patients with postprandial fullness (p=0.63), epigastric pain or burning (p=0.26), gastroesophageal reflux symptoms (p=0.13), allergy and food intolerance (p=0.42) and smoking (p=0.28). There was no relationship between duodenal mastocytosis and early satiety (p=0.98), postprandial fullness (p=0.78), and epigastric pain or burning (p=0.82). Conclusions: Duodenal eosinophilia was similar in FD and controls. In subgroup analysis, duodenal eosinophilia occurs in patients with early satiety.

Modified medical research council (mMRC) e a sua relação com variáveis respiratórias e o tempo de internação em pacientes hospitalizados com doença pulmonar obstrutiva crônica / Modified medical research council (mMRC) and their relation with respiratory variables and the time of intermission in hospitalized patients with chronic obstructive pulmonary disease

Objetivo: Correlacionar a sensação de dispneia obtida pela escala Medical Research Council modificada (mMRC) com as variáveis respiratórias e o tempo de internação em portadores de doença pulmonar obstrutiva crônica (DPOC) hospitalizados. Material e Métodos: Estudo transversal de caráter observacional e descritivo; no qual participaram do estudo pacientes interna-dos na Santa Casa de Misericórdia (SCM) de Goiânia-GO e Hospital Geral de Goiânia Dr. Alberto Rassi (HGG), com diag-nóstico de DPOC. Foram coletados sinais vitais, dados antro-pométricos e aplicada a escala de mMRC. Resultados: Foram avaliados 28 participantes, com média de idade de 74,10±12,46 anos; a média de mMRC foi de 3,10±1,19, comprometimento moderado, não ocorrendo diferença de mMRC entre homens e mulheres (p=0,503), além de não ter sido encontrada cor-relação entre o mMRC com a FR (r= -0,035 p=0,864), SpO2 (r=-0,228 p=0,222) e o tempo de internação (r=0,140 p=0,486). No entanto, em relação a necessidade de internação em uni-dade de terapia intensiva e o tempo de internação na unidade houve correlação significativa (r-0,457 p<0,01 e r 0,388 p<0,04, respectivamente). Conclusão: Não se encontrou relação da sensação de dispneia com as variáveis respiratórias e o tempo de internação total, porém foi possível verificar uma correlação entre o mMRC e a necessidade de internação e o tempo de internação em unidade de terapia intensiva. (AU)

Objetive:To correlate the dyspnea syndrome with the modified Medical Research Council scale (mMRC) with the respiratory and temporal variables of hospitalization in patients with hospitalized chronic obstructive pulmonary disease (COPD). Method: Cross-sectional observational and descriptive studyin which participated patients from the Santa Casa de Misericórdia (SCM) of Goiânia-GO and the General Hospital of Goiânia Dr. Alberto Rassi (HGG), with the diagnosis of COPD. Vital signs and anthropometric data were collected and the mMRC scale was applied. Results: Twenty-eight participants were evaluated, with a mean age of 74.10 ± 12.46 years; the mean mMRC was 3.10 ± 1.19, there was moderate impairment, no difference of mMRC between men and women (p = 0.503), nor was it found among mMRC with FR (r = -0.035 p = 0.864), SpO2 (r = -0.228 p = 0.222) and length of stay (r = 0.140 p = 0.486), which means that intensive care unit stay and length of stay in the domestic unit are important (r-0,457 p<0,01 e r 0,388 p<0,04 respectively). Conclusion: No differences between dyspnea syndrome and respiratory variables and total hospitalization time were found, but it was possible that they occurred between the MRC and the need for hospitalization and length of stay in intensive care therapy. There is a moderate influence of the dyspnea syndrome to direct the attention to the individuals under hospitalization, in order to minimize the progression of the disorder and greater impairment in the general state of health. (AU)

Percepción de carga de la enfermedad en la persona con enfermedad crónica / Percepção de carga da doença na pessoa com doença crónica / Perception of cost of illness among chronically ill people

RESUMEN Objetivo: Describir el perfil y la Percepción de carga de la enfermedad en personas con enfermedad crónica e identificar correlaciones entre la Percepción de carga reportada y las variables sociodemográficas y de cuidado de la persona. Material y Método: Estudio cuantitativo, descriptivo correlacional de corte transversal realizado con una muestra de 240 personas con enfermedad crónica en tres instituciones de salud. Se midió la Percepción de carga de la enfermedad con el instrumento Carga de la Enfermedad Crónica para el Paciente GCPC-UN y las variables sociodemográficas de los participantes con una encuesta de caracterización. Para el análisis de los datos se usó estadística descriptiva y para identificar las correlaciones se usó el estadístico Rho de Spearman. Resultados: Sobre la Percepción de carga se encontró que hay mayor impacto de la enfermedad en el Disconfort físico del paciente, seguido del impacto en los Aspectos socioculturales y familiares y, finalmente, en el Sufrimiento emocional y espiritual. La Percepción de carga de la enfermedad se relacionó con la edad (r= -,173; p= 0,007), el tiempo con la enfermedad (r= -,182; p= 0,005) y el número de horas de cuidado diario (r= ,357; p= 0,000). Conclusión: Las personas con enfermedad crónica perciben carga por la enfermedad principalmente en lo relacionado con el Disconfort físico que esta genera. Existe una asociación entre la Percepción de carga de la enfermedad con variables sociodemográficas como la edad, el tiempo con la enfermedad y las horas de cuidado diario. En este caso los profesionales de la salud deben prestar atención a la atención integral de los pacientes con enfermedad crónica en todas sus dimensiones.

ABSTRACT Objective: To describe the profile and Perception of cost of illness among people with chronic disease and to identify the correlations between the reported cost and the socio-demographic and care variables of the patient. Material and Method: A quantitative, cross-sectional, descriptive, correlational study conducted with a sample of 240 people with chronic disease in three healthcare institutions. The Cost of illness perception was measured using the instrument Chronic Disease Burden for the Patient GCPC-UN and a characterization survey for the socio-demographic variables of the participants. For the data analysis, descriptive statistics were used and the Spearman's Rho to identify correlations. Results: Regarding perception of cost, it was found that there is a greater impact on the disease in the Physical discomfort of the patient, followed by the impact on Sociocultural and family aspects and, finally, on Emotional and spiritual suffering. Cost of illness was related to age (r = -.173; p = 0.007), time with disease (r = -.182; p = 0.005) and the number of hours of daily care (r = .357; p = 0.000). Conclusion: People with chronic disease show Cost of illness mainly related to the Physical discomfort that it generates. There is a relationship between Cost of illness and socio-demographic variables such as age, time with disease and hours of daily care. Healthcare professionals should thus pay attention to the comprehensive care of patients with chronic disease in all its dimensions.

RESUMO Objetivo: Descrever o perfil e a Percepção de carga da doença em pessoas com doença crónica e identificar a correlação entre os efeitos reportados e as variáveis sociodemográficas e de cuidado das pessoas. Material e Método: Estudo quantitativo, descritivo correlacional, de corte transversal realizado com uma amostra de 240 pessoas com doença crónica, em três instituições de saúde. A Percepção de carga da doença foi medida com o instrumento Carga da Doença para o Paciente GCPC-UN e as variáveis sociodemográficas dos participantes com uma pesquisa de caracterização. Para analisar os dados foi utilizada a estadística descritiva e para identificar a correlação utilizou-se o estadístico de Rho de Spearman. Resultados: Em relação à Percepção de carga da doença, identificou-se que existe maior impacto na doença no Desconforto físico do paciente, seguido do impacto nos Aspectos socioculturais e familiares e, finalmente, no Sofrimento emocional e espiritual. A Percepção de carga da doença teve relação com idade (r= -,173; p= 0,007), tempo com a doença (r= -,182; p= 0,005) e o número de horas de cuidado por dia (r= ,357; p= 0,000). Conclusão: As pessoas com doença crónica apresentam Carga da doença relacionada, principalmente, com o Desconforto físico que produz. Existe uma relação entre a Percepção de carga da doença e as variáveis sociodemográficas como idade, tempo com a doença e horas de cuidado por dia. Os profissionais da saúde, neste caso, devem prestar atenção ao cuidado integral dos pacientes com doença crónica em todas suas dimensões.